Calendar BioScrip Inc Nasdaq
Stocks
US09069N1081
Healthcare Facilities & Services
Upcoming events on BioScrip Inc
No events available
Past events on BioScrip Inc
| 29/07/2026 | Earnings presentation | 16:30 |
| 29/07/2026 | Earnings release - Q2 2026 | |
| 20/05/2026 | Présentation aux Actionnaires / Analystes | 23:00 |
| 20/05/2026 | Annual General Meeting | 23:00 |
| 30/04/2026 | Earnings release - Q1 2026 | |
| 30/04/2026 | Earnings presentation | 16:30 |
| 24/02/2026 | Earnings presentation | 17:30 |
| 24/02/2026 | Earnings release - Q4 2025 | |
| 30/10/2025 | Earnings presentation | 16:30 |
| 30/10/2025 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 302 4 269 0.79% | 4 998 4 938 1.21% | 5 650 5 648 0.02% | 5 753 | 6 133 | 6 636 |
|
EBITDA Million USD | Released Forecast Spread | 425 423 0.47% | 444 441 0.74% | 471 471 0.07% | 483 | 520 | 567 |
|
EBIT Million USD | Released Forecast Spread | 315 316 -0.39% | 322 326 -1.39% | 338 342 -1.31% | 372 | 410 | 461 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 359 336 6.68% | 284 279 1.6% | 283 282 0.16% | 316 | 352 | 392 |
|
Net income Million USD | Released Forecast Spread | 267 260 2.84% | 212 207 2.11% | 208 209 -0.69% | 226 | 252 | 281 |
|
EPS USD | Released Forecast Spread | 1,48 1,44 3% | 1,23 1,20 2.18% | 1,27 1,28 -0.65% | 1,50 | 1,70 | 1,93 |
| Announcement Date | 22/02/24 | 26/02/25 | 24/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 | 2028 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 346 1 286 4.66% | 1 333 1 257 6% | 1 416 1 353 4.67% | 1 435 1 413 1.58% | 1 465 1 463 0.15% | 1 351 1 397 -3.29% | 1 442 1 419 1.65% | 1 474 | 1 486 | 1 446 | 1 539 | 1 573 | 1 600 | 1 579 | 1 687 |
|
EBITDA Million USD | Released Forecast Spread | 122 119 2.46% | 112 103 8.76% | 114 111 2.94% | 119 118 1.02% | 126 126 0.39% | 105 103 1.72% | 117 113 3.78% | 124 | 137 | 114 | 126 | 134 | 147 | 129 | 138 |
|
EBIT Million USD | Released Forecast Spread | 87,0 89,4 -2.61% | 79,2 75,1 5.46% | 82,7 85,1 -2.79% | 84,5 90,8 -6.96% | 91,5 93,7 -2.31% | 72,5 77,2 -5.98% | 85,1 88,7 -4.06% | 97,2 | 110 | 89,6 | 101 | 107 | 119 | 105 | 114 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 81,0 75,1 7.97% | 63,6 58,3 9.02% | 68,9 69,7 -1.18% | 69,0 73,8 -6.49% | 81,5 80,3 1.56% | 61,0 62,2 -1.96% | 74,0 72,4 2.15% | 84,1 | 95,4 | 73,6 | 83,9 | 91,0 | 104 | 82,9 | 89,9 |
|
Net income Million USD | Released Forecast Spread | 60,1 54,9 9.48% | 46,7 44,5 5.04% | 50,5 53,0 -4.71% | 51,8 56,5 -8.22% | 58,5 59,9 -2.39% | 45,3 45,0 0.84% | 53,9 52,8 2.01% | 59,0 | 68,1 | 53,0 | 60,9 | 65,2 | 73,8 | 60,9 | 66,1 |
|
EPS USD | Released Forecast Spread | 0,35 0,33 6.61% | 0,28 0,27 3.23% | 0,31 0,32 -1.91% | 0,32 0,34 -5.94% | 0,37 0,37 -0.45% | 0,29 0,28 3.37% | 0,35 0,33 5.24% | 0,39 | 0,45 | 0,36 | 0,41 | 0,45 | 0,51 | 0,42 | 0,46 |
| Announcement Date | 26/02/25 | 29/04/25 | 30/07/25 | 30/10/25 | 24/02/26 | 30/04/26 | 29/07/26 | - | - | - | - | - | - | - | - |
| 06/10/2026 |  | Ex-dividend date - 0.86 USD | 08:00 |
| 12/10/2026 | | Information meeting | 17:00 |
| 15/10/2026 | | Extraordinary General Meeting | 09:30 |
| 19/10/2026 | | Extraordinary General Meeting | |
| 22/10/2026 | | Earnings release - Q3 2026 | |
| 22/10/2026 | | Earnings presentation | 16:30 |
| 22/10/2026 | | Board of Directors Meeting | |
| 22/10/2026 | | Earnings release - Q3 2026 | |
| 27/10/2026 | | Earnings release - Q3 2026 | |
| 28/10/2026 | | Sales and Revenue Release - Q3 2026 | AH |
Past sector events for BioScrip Inc
| 29/09/2026 | | Ex-dividend date - 0.0441 CAD | 08:00 |
| 25/09/2026 | | Ex-dividend date for special dividend - 0.18411 BRL | 08:00 |
| 22/09/2026 | | Présentation aux Actionnaires / Analystes | 06:30 |
| 18/09/2026 | | Annual General Meeting | |
| 18/09/2026 | | Annual General Meeting | 15:30 |
| 18/09/2026 | | Présentation aux Actionnaires / Analystes | 15:30 |
| 16/09/2026 | | Ex-dividend date - 0.78 USD | 08:00 |
| 16/09/2026 | | Extraordinary General Meeting | 10:30 |
| 10/09/2026 | | Présentation aux Actionnaires / Analystes | 13:00 |
| 10/09/2026 | | Earnings release - Q2 2026 |
